Free Trial

Johnson & Johnson (JNJ) Earnings Date, Estimates & Call Transcripts

Johnson & Johnson logo
$157.42 +3.51 (+2.28%)
Closing price 04/17/2025 03:59 PM Eastern
Extended Trading
$157.50 +0.08 (+0.05%)
As of 04/17/2025 06:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Johnson & Johnson Earnings Summary

Latest Q1
Earnings Date
Apr. 15Estimated
Consensus EPS
(Apr. 15)
$2.59
Actual EPS
(Apr. 15)
$2.77 Beat By $0.18
Actual Revenue
(Apr. 15)
$21.89B

Johnson & Johnson announced Q1 2025 earnings on April 15, 2025, reporting an EPS of $2.77, which beat the consensus estimate of $2.59 by $0.18. Quarterly revenue was reported to be $21.89 billion, above analysts' expectations of $21.65 billion. With a trailing EPS of $6.65 and a P/E Ratio of 23.67, Johnson & Johnson's earnings are expected to grow 4.63% next year, from $10.58 to $11.07 per share.

Q1 2025 Earnings Resources

Get Johnson & Johnson Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Johnson & Johnson and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

JNJ Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

JNJ Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Johnson & Johnson Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20252$2.55$2.60$2.58 
Q2 20252$2.56$2.69$2.63 
Q3 20252$2.74$2.78$2.76 
Q4 20252$2.48$2.56$2.52 
FY 20258$10.33$10.63$10.48 
Q1 20261$2.66$2.66$2.66 
Q2 20261$2.76$2.76$2.76 
Q3 20261$2.79$2.79$2.79 
Q4 20261$2.83$2.83$2.83 
FY 20264$11.04$11.04 $11.04

Johnson & Johnson Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
4/15/2025Q1 2025$2.59$2.77+$0.18$4.54$21.65B$21.89B
1/22/2025Q4 2024$1.99$2.04+$0.05$1.41$22.44B$22.52B
10/15/2024Q3 2024$2.21$2.42+$0.21$3.73$22.17B$22.47B
7/17/2024Q2 2024$2.71$2.82+$0.11$3.71$22.33B$22.45B
4/16/2024Q1 2024$2.64$2.71+$0.07$3.22$21.39B$21.38B
1/23/2024Q4 2023$2.28$2.29+$0.01$2.91$21.02B$21.40B
10/17/2023Q3 2023$2.52$2.66+$0.14-$4.89$21.00B$21.35B
7/20/2023Q2 2023$2.62$2.80+$0.18$3.64$24.63B$25.53B

Johnson & Johnson Earnings - Frequently Asked Questions

Johnson & Johnson (NYSE:JNJ) last announced its quarterly earning data on Tuesday, April 15, 2025. Learn more on JNJ's earnings history.

Johnson & Johnson issued an update on its FY 2025 earnings guidance on Tuesday, April, 15th. The company provided EPS guidance of 10.500-10.700 for the period, compared to the consensus earnings per share estimate of 10.500. The company issued revenue guidance of $91.0 billion-$91.8 billion, compared to the consensus revenue estimate of $90.3 billion.

In the previous quarter, Johnson & Johnson (NYSE:JNJ) reported $2.77 earnings per share (EPS) to beat the analysts' consensus estimate of $2.59 by $0.18. Learn more on analysts' earnings estimate vs. JNJ's actual earnings.

The conference call for Johnson & Johnson's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Johnson & Johnson's latest earnings report can be read online.
Read Transcript

Johnson & Johnson (NYSE:JNJ) has a recorded annual revenue of $88.82 billion.

Johnson & Johnson (NYSE:JNJ) has a recorded net income of $14.07 billion. JNJ has generated $6.65 earnings per share over the last four quarters.

Johnson & Johnson (NYSE:JNJ) has a trailing price-to-earnings ratio of 23.67 and a forward price-to-earnings ratio of 14.88. The price/earnings-to-growth ratio is 2.56.

Johnson & Johnson's earnings are expected to grow from $10.58 per share to $11.07 per share in the next year, which is a 4.63% increase.

More Earnings Resources from MarketBeat



This page (NYSE:JNJ) was last updated on 4/19/2025 by MarketBeat.com Staff
From Our Partners